In combination protocols, GHK-Cu is typically administered via subcutaneous injection at doses of 200 to 600 mcg daily
Although extremely rare, hydroxocobalamin injections can also cause serious side effects such as a major allergic reaction or irregular heartbeats (palpitations)
Tiredness, weakness, brain fog, and mood changes are often mentioned
In peripheral nerve transection, BPC-157 enhances Schwann cell proliferation and axonal outgrowth, improving nerve conduction recovery velocity
As of a January 2026 legal analysis, BPC-157 remained listed in Category 2, and the compound cannot legally be compounded under sections 503A or 503B of the Food, Drug and Cosmetic Act
doi: 10.1096/fasebj.11.6.9194528